• Nolato Q3 2022 earnings call featured CEO Christer Wahlquist, CFO Per-Ola Holmström, analysts Adrian Gilani (ABG), Carl Ragnerstam (Nordea), Johan Skoglund (DNB Markets), Michael Lofgren (Carnegie).
• Q3 net sales SEK 2.6 billion, EBITA SEK 214 million, EBITA margin 8.1%, cash flow after investments SEK 166 million; management flagged inflation and production-efficiency measures as key margin headwinds.
• Integrated Solutions sales fell about 50% as VHP volumes dropped on weaker demand, dual-sourcing, and China licensing; no VHP manufacturing in October, license expected in November, inventories set to rise, Q4 Integrated sales guided around SEK 500 million with margin seen below double digits.
• Medical Solutions sales rose 27% with roughly half from currency, margin 8.4% hit by mix shift from high-margin IVD to surgery, US manufacturing cost inflation, and underutilized capacity investments; IVD destocking persisted with possible recovery late Q4 or Q1.
• Industrial Solutions sales rose 18% with EBITA margin 5.2% as volatile automotive call-offs cut efficiency and price pass-through lagged; management avoided major cost cuts to protect customer support, while noting early signals of softer industrial demand into next year.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nolato AB published the original content used to generate this news brief on May 13, 2026, and is solely responsible for the information contained therein.